摘要
目的探讨和血明目片治疗糖尿病视网膜病变的效果。方法选择在我院诊治的糖尿病视网膜病变患者78例78眼(单眼发病),分为研究组与对照组各39例,对照组给予常规治疗,研究组在对照组治疗的基础上给予和血明目片治疗,两组都治疗观察3个月。结果研究组的总有效率显著高于对照组(P<0.05)。治疗后研究组患眼的最佳矫正视力分别高于对照组(P<0.05)。结论和血明目片在糖尿病视网膜病变治疗中的应用能改善视觉功能,提高治疗效果,有很好的应用价值。
Objective To explore the effect of hexuemingmu tablet in the treatment of diabetic retinopathy. Methods 78 eyes of 78 patients with diabetic retinopathy diagnozed and treated in our hospital were selected and divided into research group and the control group, 39 cases in each group, the control group was given conventional treatment, the research group was additionally given hexuemingmu tablet to treat on the basis of the control, all patients were treated for 3 months. Results The total effective rate of the research group was significantly higher than that of the control(P<0.05). The best corrected visual acuity of the research group was higher than that of the control(P<0.05). Conclusion The hexuemingmu tablet can improve the visual function, improve the therapeutic effect, and have good application value in the treatment of diabetic retinopathy
引文
[1]喻建锋,宋愈,朱妍,等.2型糖尿病患者干眼与糖尿病视网膜病变的相关分析[J].国际眼科杂志,2016,16(6):1187-1189.
[2]王明利.和血明目片治疗出血期眼底出血的临床效果分析[J].中国社区医师,2017,33(5):74-75.
[3]魏凌君,郑海涛.和血明目片治疗视网膜静脉阻塞性眼底出血疗效分析[J].海峡药学,2017,29(1):148-150.
[4]刘光鑫.和血明目片治疗视网膜静脉阻塞气滞血瘀证的近期疗效[J].实用临床医学,2016,17(12):63-65.
[5]钟彩玲.和血明目片和复方丹参片治疗轻、中度非增殖型糖尿病视网膜病变的效果比较[J].中国当代医药,2016,23(17):93-95.